BLFS NASDAQ
BioLife Solutions, Inc.
1W: -3.1%
1M: +3.8%
3M: +34.2%
YTD: +56.1%
1Y: +42.8%
3Y: +165.5%
5Y: -20.5%
$37.30
+0.52 (+1.41%)
Weekly Expected Move ±4.1%
$34
$36
$37
$39
$40
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
0 neutral
0 bearish
Articles (24h)
0
No articles in the last 24 hours
0.00
Neutral
0 bullish
1 neutral
0 bearish
Articles (7d)
1
Daily Sentiment (7 Days)
Articles (50)
StoneX updates its best ideas list
BioLife Solutions, Inc. $BLFS Shares Newly Bought by Engineers Gate Manager LP
BioLife Solutions, Inc. (NASDAQ:BLFS) Receives $31.38 Consensus Price Target from Analysts
Bank of New York Mellon Corp Purchases New Shares in BioLife Solutions, Inc. $BLFS
BioLife Solutions (NASDAQ:BLFS) Hits New 12-Month High – Time to Buy?
BioLife Solutions, Inc. (BLFS) Q2 Earnings and Revenues Surpass Estimates
HC Wainwright Expects Higher Earnings for BioLife Solutions
Key deals this week: Stripe, IBM, Repligen, LXP Industrial Trust and more
Notable healthcare headlines for the week: Eli Lilly, Molina Healthcare, and Roche in focus
Repligen to Expand Cell Therapy Capabilities With BioLife Buyout
BioLife is said to have drawn takeover interest from Repligen
BioLife (BLFS) Q1 2026 Earnings Transcript
Biolife outlines 2026 revenue of $112.5M-$115M while targeting full-year GAAP net income
BioLife Solutions, Inc. (BLFS) Tops Q1 Earnings and Revenue Estimates
Here are the major earnings after the close Thursday
Quanterix Corporation (QTRX) Reports Q1 Loss, Lags Revenue Estimates
ResMed (RMD) Surpasses Q3 Earnings and Revenue Estimates
Zacks Industry Outlook Highlights Phibro Animal Health, BioLife Solutions, Omeros and Brainsway
4 Medical Product Stocks to Buy From a Challenging Industry
BioLife Solutions (NASDAQ:BLFS) Stock Crosses Below 200 Day Moving Average – Time to Sell?
BioLife Solutions Wins INTERPHEX 2026 Biotech Innovation Award for CellSeal® CryoCase
Utah Medical Gains 32% in a Year: Should You Buy the Stock?
BioLife Solutions, Inc. (NASDAQ:BLFS) Given Consensus Rating of “Moderate Buy” by Brokerages
Allspring Global Investments Holdings LLC Reduces Position in BioLife Solutions, Inc. $BLFS
Wall Street Analysts Think BioLife Solutions (BLFS) Could Surge 70.78%: Read This Before Placing a Bet
Benchmark updates its best ideas list
378,550 Shares in BioLife Solutions, Inc. $BLFS Purchased by Capricorn Fund Managers Ltd
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
BioLife Solutions (NASDAQ:BLFS) Stock Passes Below 200 Day Moving Average – Should You Sell?
BioLife Solutions, Inc. (NASDAQ:BLFS) Given Consensus Recommendation of “Moderate Buy” by Brokerages
HC Wainwright Predicts Higher Earnings for BioLife Solutions
After Plunging 17.6% in 4 Weeks, Here's Why the Trend Might Reverse for BioLife Solutions (BLFS)
Wall Street Analysts Believe BioLife Solutions (BLFS) Could Rally 35%: Here's is How to Trade
FY2026 EPS Estimates for BLFS Increased by Analyst
BioLife Solutions (NASDAQ:BLFS) Shares Gap Up – What’s Next?
BioLife Solutions outlines 17–20% revenue growth target for 2026 while expanding commercial customer mix
BioLife Solutions, Inc. (BLFS) Q4 2025 Earnings Call Transcript
BioLife Solutions GAAP EPS of $0.04 beats by $0.06, revenue of $24.76M beats by $0.75M
BioLife Solutions, Inc. (BLFS) Surpasses Q4 Earnings and Revenue Estimates
BioLife Solutions Reports Fourth Quarter and Full Year 2025 Financial Results from Continuing Operations
Here are the major earnings after the close Thursday
BioLife Solutions to Report Fourth Quarter and Full Year 2025 Financial Results and Business Update on February 26, 2026
BioLife Solutions Signs Multi-Year Supply Agreement with Qkine Limited to Expand its Product Portfolio into the Rapidly Growing Cytokines Market
BioLife Solutions (NASDAQ:BLFS) Stock Price Crosses Below 200 Day Moving Average – Time to Sell?
Campbell & CO Investment Adviser LLC Grows Stake in BioLife Solutions, Inc. $BLFS
Contrasting Generation Alpha (OTCMKTS:GNAL) and BioLife Solutions (NASDAQ:BLFS)
BioLife Solutions Announces Preliminary Fourth Quarter and Full Year 2025 Unaudited Revenue from Continuing Operations
BioLife Solutions' CFO Sells 30,000 Shares
Commonwealth of Pennsylvania Public School Empls Retrmt SYS Buys Shares of 9,524 BioLife Solutions, Inc. $BLFS
BioLife Solutions Unveils the Aby J. Mathew Center for Biopreservation Excellence